Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $550.00

Intuitive Surgical (NASDAQ:ISRG) had its target price increased by Robert W. Baird from $513.00 to $550.00 in a report released on Wednesday morning, Marketbeat reports. Robert W. Baird currently has an outperform rating on the medical equipment provider’s stock.

Several other analysts have also recently commented on ISRG. Raymond James Financial restated an “outperform” rating and set a $480.00 price objective on shares of Intuitive Surgical in a research note on Wednesday. Wells Fargo & Company reaffirmed an “overweight” rating and issued a $486.00 price objective (down from $487.00) on shares of Intuitive Surgical in a report on Wednesday. Piper Sandler reiterated an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, August 21st. Leerink Partners reduced their target price on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a report on Friday, July 17th. Finally, Stifel Nicolaus decreased their target price on shares of Intuitive Surgical from $670.00 to $550.00 and set a “buy” rating for the company in a research report on Friday, July 17th. Twenty-three equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $493.54.

Intuitive Surgical Stock Up 1.9%

Intuitive Surgical stock opened at $452.29 on Wednesday. Intuitive Surgical has a 52 week low of $328.57 and a 52 week high of $603.88. The company has a market capitalization of $156.78 billion, a price-to-earnings ratio of 49.76, a price-to-earnings-growth ratio of 3.31 and a beta of 1.46. The stock has a 50-day moving average price of $395.50 and a 200 day moving average price of $409.13.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The firm had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. During the same quarter in the prior year, the firm earned $2.40 earnings per share. Intuitive Surgical’s revenue for the quarter was up 21.7% on a year-over-year basis. Research analysts anticipate that Intuitive Surgical will post 8.87 EPS for the current fiscal year.

Insider Activity

In other Intuitive Surgical news, EVP Gary Loeb sold 400 shares of the business’s stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total value of $151,600.00. Following the completion of the transaction, the executive vice president directly owned 5,320 shares of the company’s stock, valued at approximately $2,016,280. The trade was a 6.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 72 shares of the company’s stock in a transaction that occurred on Tuesday, August 11th. The stock was sold at an average price of $393.10, for a total value of $28,303.20. Following the completion of the sale, the director owned 179 shares in the company, valued at approximately $70,364.90. This represents a 28.69% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 12,370 shares of company stock valued at $4,891,989 over the last 90 days. Company insiders own 0.60% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

Institutional investors have recently made changes to their positions in the company. Bank of New York Mellon Corp purchased a new stake in shares of Intuitive Surgical during the 2nd quarter worth about $1,335,753,000. Arrowstreet Capital Limited Partnership grew its position in shares of Intuitive Surgical by 95.3% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after acquiring an additional 1,027,475 shares during the period. Assenagon Asset Management S.A. grew its position in shares of Intuitive Surgical by 55.8% during the 3rd quarter. Assenagon Asset Management S.A. now owns 1,557,940 shares of the medical equipment provider’s stock valued at $633,505,000 after acquiring an additional 558,099 shares during the period. Amundi increased its stake in shares of Intuitive Surgical by 8.6% in the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after purchasing an additional 193,096 shares in the last quarter. Finally, Temasek Holdings Private Ltd increased its stake in shares of Intuitive Surgical by 416.4% in the 1st quarter. Temasek Holdings Private Ltd now owns 227,211 shares of the medical equipment provider’s stock valued at $104,742,000 after purchasing an additional 183,211 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical reported third-quarter revenue of approximately $3.05 billion, up more than 20% year over year, while earnings exceeded consensus expectations. The company also highlighted continued international expansion and adoption of its robotic-surgery systems. Intuitive Surgical Stock: Margin Hit Masks Strong Q3 Growth Story
• Positive Sentiment: Several firms remain constructive: BTIG, Stifel Nicolaus, Piper Sandler, and Oppenheimer reaffirmed or maintained Buy ratings. Baird also raised its price target, while Erste Group upgraded the stock to Buy. ISRG was added to the Zacks Rank #1 Strong Buy list. New Strong Buy Stocks for October 23rd
• Neutral Sentiment: The quarter included roughly $450 million of costs tied to an antitrust settlement, along with pricing-related pressure, which reduced margins. These items appear largely nonrecurring, but investors are assessing their effect on near-term profitability. Intuitive Surgical Reports Q3 2026 Earnings Impacted by $450M Antitrust Settlement
• Negative Sentiment: The key concern is that U.S. da Vinci procedure growth slowed to its lowest level since the COVID period. Investors worry that decelerating domestic demand could make it harder for Intuitive Surgical to sustain its premium valuation, which remains above 50 times earnings. Intuitive Surgical Sinks as U.S. da Vinci Growth Slows
• Negative Sentiment: RBC lowered its expectations for ISRG, and an analyst downgrade contributed to a gap lower in the shares. The market is emphasizing forward growth and valuation rather than the headline earnings beat. Intuitive Surgical Shares Gap Down Following Analyst Downgrade

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.